Merz Therapeutics

Merz Therapeutics Seeks to Meet the Unique Needs of Individuals with Movement Disorders, Neurological Conditions, and Other Health Issues Significantly Impacting Patients' Quality of Life. With a patient-centered approach, cutting-edge research and development efforts, highly scientific medical affairs resources, and a dedicated commercial team, we continue to advance new standards in personalized treatments, including botulinum toxin. Merz Therapeutics, a subsidiary of Merz Group, is headquartered in Frankfurt, Germany, with operations in over 90 countries.